Outcome of central hepatectomy for hepatoblastomas
- PMID: 20223320
- DOI: 10.1016/j.jpedsurg.2009.09.025
Outcome of central hepatectomy for hepatoblastomas
Abstract
Background/purpose: Central hepatoblastomas (CHBL) involving liver segments (IV + V) or (IV + V + VIII) are in contact with the portal bifurcation. Their resection may be achieved by central hepatectomy (CH) with thin resection margins on both sides of the liver pedicle, by extended right or left hepatectomy with thin resection margins on one side, or by liver transplantation with thick free margins. The aim of this study is to assess the operative and postoperative outcome of CH for hepatoblastoma.
Methods: This was a retrospective monocentric study of 9 patients who underwent CH for CHBL between 1996 and 2008.
Results: The operative time was 4 hours 50 minutes (2 hours 20 minutes to 7 hours), vascular clamping lasted 30 minutes (0-90 minutes), and the amount of blood cell transfusion was 250 mL (0-1800 mL). Two patients had biliary leakage requiring percutaneous drainage. Median follow-up time was 27 months (14-120 months). All of 8 nonmetastatic patients are alive and disease-free; 1 metastatic patient died of recurrent metastases at last follow-up. Although 3 of 9 patients had surgical margins less than 1 mm, none, including the patients who died from metastases, had local recurrence.
Conclusions: Our study demonstrates the feasibility of CH for CHBL without operative mortality or local recurrence. Central hepatectomy is an alternative to extensive liver resections in selected patients.
Similar articles
-
[Differentiated treatment protocols for high- and standard-risk hepatoblastoma--an interim report of the German Liver Tumor Study HB99].Klin Padiatr. 2003 May-Jun;215(3):159-65. doi: 10.1055/s-2003-39375. Klin Padiatr. 2003. PMID: 12778356 Clinical Trial. German.
-
Surgical strategies for unresectable hepatoblastomas.J Pediatr Surg. 2012 Dec;47(12):2194-8. doi: 10.1016/j.jpedsurg.2012.09.006. J Pediatr Surg. 2012. PMID: 23217875
-
Survival after liver transplantation for hepatoblastoma: a 2-center experience.J Pediatr Surg. 2008 Nov;43(11):1973-81. doi: 10.1016/j.jpedsurg.2008.05.031. J Pediatr Surg. 2008. PMID: 18970927
-
[Diagnosis and treatment of colorectal liver metastases - workflow].Zentralbl Chir. 2008 Jun;133(3):267-84. doi: 10.1055/s-2008-1076796. Zentralbl Chir. 2008. PMID: 18563694 Review. German.
-
Fetal and neonatal hepatic tumors.J Pediatr Surg. 2007 Nov;42(11):1797-803. doi: 10.1016/j.jpedsurg.2007.07.047. J Pediatr Surg. 2007. PMID: 18022426 Review.
Cited by
-
Simpson-Golabi-Behmel syndrome type 1 in a neonate with central hepatoblastoma.BMJ Case Rep. 2025 Jan 29;18(1):e262331. doi: 10.1136/bcr-2024-262331. BMJ Case Rep. 2025. PMID: 39880477 Free PMC article.
-
Role of Mesohepatectomy for Pediatric Centrally Located Liver Tumors.J Indian Assoc Pediatr Surg. 2024 Jan-Feb;29(1):51-55. doi: 10.4103/jiaps.jiaps_190_23. Epub 2024 Jan 12. J Indian Assoc Pediatr Surg. 2024. PMID: 38405259 Free PMC article.
-
Outcome analysis of surgical complications in pediatric solid tumors: a retrospective clinical study.Pediatr Surg Int. 2025 Jul 1;41(1):201. doi: 10.1007/s00383-025-06069-9. Pediatr Surg Int. 2025. PMID: 40590960
-
Primary malignant liver tumors in children.Indian J Pediatr. 2012 Jun;79(6):793-800. doi: 10.1007/s12098-012-0704-1. Epub 2012 Mar 1. Indian J Pediatr. 2012. PMID: 22382512 Review.
-
International Society of Paediatric Surgical Oncology (IPSO) Surgical Practice Guidelines.Ecancermedicalscience. 2022 Feb 17;16:1356. doi: 10.3332/ecancer.2022.1356. eCollection 2022. Ecancermedicalscience. 2022. PMID: 35510137 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical